# Why do few Medicare beneficiaries switch their Part D prescription drug plans? Insights from behavioral sciences

**Authors:** Nathan Hodson, Wändi Bruine de Bruin

PMC · DOI: 10.1057/s41271-025-00618-1 · Journal of Public Health Policy · 2025-12-23

## TL;DR

Many Medicare beneficiaries don't switch prescription drug plans due to behavioral challenges like information overload and low trust, despite the potential for better value.

## Contribution

The paper introduces behavioral science-based solutions to help beneficiaries overcome barriers to switching Medicare Part D plans.

## Key findings

- Beneficiaries often overpay due to behavioral barriers like information overload and low trust.
- Price cues influence pharmacy choice and medication adherence but not plan switching.
- Behavioral interventions could improve beneficiaries' ability to find better value in drug plans.

## Abstract

Medicare Part D innovatively included a market in public health insurance in the United States. Proponents argued that increased competition would drive better value for beneficiaries, but others feared that beneficiaries would struggle to navigate the complex program. Understanding how Part D beneficiaries choose between plans allows us to evaluate the extent to which Medicare Part D succeeds at increasing value to beneficiaries and where there is scope to support beneficiaries. Many Part D beneficiaries are sensitive to price cues in relation to pharmacy choice and medication adherence, yet frequently overpay for their plans. Empirical literature suggests that behavioral aspects including information overload, low salience, low trust, and practical ‘sludge’ all partly contribute to failure to switch. We propose solutions to address these barriers based on behavioral insights.

## Full-text entities

- **Diseases:** cancer (MESH:D009369), sludge':prevent (MESH:D000079263)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13008778/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC13008778/full.md

---
Source: https://tomesphere.com/paper/PMC13008778